A carregar...
The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?
Specific mutations in epidermal growth factor receptor (EGFR) gene are predictive for response to the EGFR tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer patients (NSCLC). According to international guidelines, the molecular testing in patients with advanced NSCLC of a non-squamous...
Na minha lista:
| Publicado no: | Ann Transl Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5326656/ https://ncbi.nlm.nih.gov/pubmed/28251125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.01.32 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|